GC Biopharma Corp. (006280) Stock Statistics & Valuation Metrics

GC Biopharma Corp. has a market cap or net worth of ₩1.29T. The enterprise value is $2.58M.

GC Biopharma Corp. has 11,686,538 shares outstanding. The number of shares has decreased by -2.65% in one year.

GC Biopharma Corp.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 2.33%.

The current PE Ratio of GC Biopharma Corp. is ―. GC Biopharma Corp.’s PEG ratio is 4.72.

In the last 12 months, GC Biopharma Corp. had revenue of 1.99T and earned -4.67B in profits. Earnings per share was -409.51.

In the last 12 months, operating cash flow was 161.14B and capital expenditures -110.51B, giving a free cash flow of 50.63B billion.

GC Biopharma Corp. pays an annual dividend of ―, resulting in a dividend yield of ―

GC Biopharma Corp. upcoming earnings date is Aug 5, 2026, TBA (Confirmed).

GC Biopharma Corp. as a current ratio of 1.20, with Debt / Equity ratio of 74.42%

In the past 12 months, GC Biopharma Corp. has paid -5.65B in taxes.

GC Biopharma Corp. EV to EBITDA ratio is 17.67, with an EV/FCF ratio of 101.38.

GC Biopharma Corp. has ₩42.73B in cash and marketable securities with ₩914.33B in debt, giving a net cash position of -₩871.60B billion.

Gross margin is 26.50%, with operating margin of 3.41%, and net profit margin of -0.23%.

The average price target for GC Biopharma Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―